More articles from Current Drug Therapy
- New drugs for reducing cardiovascular risk in women
Strategies to reduce cardiovascular risk in women, focusing on new drugs to treat diabetes and hyperlipidemia.
- Carvedilol for heart failure: Renewed interest in beta blockers
The idea of using beta blockers to treat heart failure seems counterintuitive. But Carvedilol is changing that thinking.
- How physicians can prevent medication errors: practical strategies
Until improved systems are in place to detect and analyze medication errors, physicians can prevent many serious medication errors by observing some basic safety practices.
- Cosmetic use of alpha-hydroxy acids
Alpha-hydroxy acids exfoliate dead skin cells, moisturize the skin, and possibly rejuvenate skin damaged by photoaging.
- Troglitazone: a new antihyperglycemic agent
Indications for and use of the newest oral drug for the treatment of type II diabetes.
- The role of azole antifungal agents for systemic antifungal therapy
The azoles have not supplanted amphotericin B for managing most serious fungal infections, hut they offer alternatives in a variety of unique situations.
- New antidepressants: more options for tailoring treatment
The newer antidepressants cause fewer, less severe side effects than older drugs. Differing mechanisms of action of these new agents offer additional options for tailoring treatment to individual patients.
- Current issues in menopausal hormone replacement therapy
For most menopausal women, the benefits of hormone replacement therapy out-weigh the risks, despite the fears aroused by an unproven link to breast cancer.
- Conscious sedation: what an internist needs to know
The use of conscious sedation rather than general anesthesia is increasing in the shift to outpatient care, but the technique poses its own special dangers.
- Advances in cluster headache management
Cluster headache is often misdiagnosed, and, until recently, therapy was difficult. Verapamil has revolutionized treatment.